First entries: menopause symptoms and therapies, cited

Menowise’s first entries are live. This opening set covers core menopause topics, each resolved from per-source signals and cited to named clinical guidelines:

• Vasomotor symptoms (hot flushes, night sweats)
• Genitourinary syndrome of menopause
• Menopausal hormone therapy
• Local vaginal estrogen
• Fezolinetant

Sources this batch: The Menopause Society’s 2022 Hormone Therapy, 2023 Nonhormone Therapy, and 2020 Genitourinary Syndrome of Menopause position statements, and the 2025 AUA/SUFU/AUGS guideline on GSM. Every entry carries an honest evidence-strength label and its citations.

Deliberately few and careful, not broad — the corpus grows one cited entry at a time. Not medical advice: menowise aggregates and organizes what the literature reports; it does not diagnose, advise, or recommend treatment.